120309-35-5

Basic information

• Product Name: Propanamide, N-(2-methoxy-5-nitrophenyl)-
• CAS NO: 120309-35-5
• Molecular Formula: C10H12N2O4
• Molecular Weight: 224.216
• Mol File: 120309-35-5.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: Propanamide, N-(2-methoxy-5-nitrophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Propanamide, N-(2-methoxy-5-nitrophenyl)-(120309-35-5)
• EPA Substance Registry System: Propanamide, N-(2-methoxy-5-nitrophenyl)-(120309-35-5)

Safety Data

• Hazardous Substances Data: 120309-35-5(Hazardous Substances Data)

Upstream product

• 79-03-8 propionyl chloride 
• 99-59-2 3-amino-4-methoxynitrobenzene 
• 123-62-6 propionic acid anhydride 

Downstream Products

• 959687-60-6 C₃₅H₄₂N₄O₃ 
• 959687-58-2 C₃₅H₄₀N₂O₃S 
• 943519-86-6 C₂₂H₃₀N₄O₄S 
• 943519-41-3 5-(2,4-bisbenzyloxy-5-isopropylphenyl)-4-[4-methoxy-3-(methyl(propyl)amino)phenyl]-4H-[1,2,4]triazol-3-ol 
• 943519-45-7 N-(5-isothiocyanato-2-methoxyphenyl)-N-methylpropylamine 
• 943519-39-9 4-methoxy-N³-methyl-N³-propylbenzene-1,3-diamine 
• 943519-44-6 N-(2-methoxy-5-nitrophenyl)-N-methylpropylamine 
• 943519-40-2 2,4-bisbenzyloxy-5-isopropyl-N-[4-methoxy-3-(methyl(propyl)amino)phenyl]benzamide 
• 1400659-71-3 C₁₇H₁₈N₂O₃ 
• 169321-23-7 N-(5-amino-2-methoxyphenyl)propionamide 
• 943519-43-5 N-(2-methoxy-5-nitrophenyl)-N-methylpropionamide 

Relevant articles and documents

Method for treating proliferative disorders associated with mutations in c-Met

The present invention relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for treating c-Met associated cancers, in a subject in need thereof.

Method for treating proliferative disorders associated with protooncogene products

The present invention relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for treating Bcr-Abl, FLT-3, EGFR, c-Kit, B-raf, and NPM-ALK associated cancers, in a subject in need thereof.

METHOD FOR TREATING INFECTIONS

The present invention relates to compounds that inhibit the activity of Hsp90 and methods of using these compounds for treating or preventing infection.